Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
SummaryThis comprehensive report contains 402 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Italian coagulation testing market during the next five years.
The report explores business and technological trends in the Italian coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,
Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis
- Sales and market shares of major
instrument and reagent suppliers.
- Extensive strategic profiles of
major suppliers and emerging market entrants.
Market Segmentation Analysis
- Comprehensive market
segmentation analysis, including:
- Commercial/Private Laboratories
- Test volume forecasts for over 40 major procedures
by market segment.
Current and Emerging Products
- Review of established and emerging procedures.
- Comparison of automated and semi-automated
analyzers from Diagnostica Stago, Helena, IL,
Siemens, Sysmex and other suppliers.
- Analysis of current and emerging technologies
and their potential market applications.
- Comprehensive lists of companies developing
or marketing new technologies and products by test.
- Product development and business expansion
opportunities with significant market appeal.
- Ideal product models with tentative
prices and operating characteristics.
- Alternative market penetration
strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.
Contains 402 pages and 35 tables
SIMILAR MARKET STUDIES
This new report from VPGMarketResearch provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: - Blood Banking - Cancer - Chemistry - Coagulation - ...
November 2015 | $3200 | View Details >>
Complete report $18,500. DataPack (test volumes, sales forecasts, supplier shares) $7,400.This 7-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years. The report explores future marketing and technological trends in seven countries; provides market share ...
March 2017 | $0 | View Details >>
2016 Emerging Opportunities in the US Home/Self Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood -Business Challenges and Marketing Strategies for Suppliers -Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
This new 175-page report from VPGMarketResearch.com provides analysis of the major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition ...
October 2015 | $450 | View Details >>
2015 World Antithrombin III Testing Market: Ambulatory Centers, Commercial Labs, Hospitals, Physician Offices, POC/Point-of-Care Locations-Competitive Landscape, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and AT III testing specifically, will become more standardized, ...
September 2015 | $2800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research